Aethlon Medical has enroled the first patient in its Australian clinical trial evaluating the safety, feasibility, and optimal dosing of the Hemopurifier device in...
Irish absorbable tech company, Vivasure Medical, has announced results from a US Investigational Device Exemption (IDE) PATCH pivotal trial finding that its fully absorbable...
Cardiawave said its device for the treatment of severe symptomatic calcific aortic stenosis (CAS) met the primary endpoint in a pivotal study. The investigational...
Sonablate announced the first patient enrolment in its HIFIVE U.S. clinical trial, which is testing high-intensity focused ultrasound (HIFU) for the noninvasive treatment of...
BlueWind Medical shared two-year data from the OASIS pivotal study of its implantable tibial neuromodulation (iTNM) system. Park City, Utah-based BlueWind said investigators presented...
Corvia Medical announced three-year positive results from its clinical trial of its Corvia Atrial Shunt.
The REDUCE LAP-HF randomized trial evaluated the safety and efficacy...
Tioga Cardiovascular, a Shifamed portfolio company, announced the first-in-human implants for its Luna TMVR system.
Luna, a 28 Fr. transcatheter mitral valve replacement (TMVR) system,...
Luna Diabetes launched a pivotal trial for Luna, its miniature automated insulin delivery system. The company describes the system — designed to transform nighttime...